Showing results (621-630 of 647) with videos related to

Sort By:
Pageof 65
AJNR. American Journal of Neuroradiology|June 15, 2019
Quantification of DTI in the Pediatric Spinal Cord: Application to Clinical Evaluation in a Healthy Patient PopulationB B Reynolds, S By, Q R Weinberg, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2H F Boyd, B Hammond, D M Hickey, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptorK Y Avenell, I Boyfield, M C Coldwell, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2000
2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S T Flynn, D M Hickey, et al.
Bioorganic & Medicinal Chemistry|July 10, 1999
Non-thiazolidinedione antihyperglycaemic agents. Part 3: The effects of stereochemistry on the potency of alpha-methoxy-beta-phenylpropanoic acidsD Haigh, G Allen, H C Birrell, et al.
Journal of Virology|December 21, 2018
Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma MembraneS E Smith, D C Busse, S Binter, et al.
European Journal of Neurology|October 17, 2018
Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studiesJ Petimar, É O'Reilly, H-O Adami, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gammaP W Young, D R Buckle, B C Cantello, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
Pageof 65